NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025

Viking Therapeutics (NasdaqCM:VKTX) has experienced a share price increase of 20% over the last month. This comes amidst the company's report of increased financial losses, with a net loss of $46 million in Q1 2025, up from $27 million the previous year, and a change in their auditing firm from Marcum to CBIZ. While these company-specific events likely added some pressure, broader market trends including a significant S&P 500 rally, driven by optimistic earnings reports and potential easing...
NYSE:CSL
NYSE:CSLBuilding

Carlisle Companies (NYSE:CSL) Announces Board Resignations Under Governance Guidelines

In the wake of recent notable executive changes, Carlisle Companies (NYSE:CSL) experienced a 10% rise in share price over the past month. These board retirements, alongside the election of a new Lead Independent Director, aligned with the company's director refreshment policy and may have contributed to a positive investor sentiment. Additionally, the broader market trend was supportive, with major indices like the S&P 500 on a strong winning streak following upbeat employment data and...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

DexCom (NasdaqGS:DXCM) Announces US$750M Buyback and Reiterates 2025 Earnings Guidance

DexCom (NasdaqGS:DXCM) recently announced a $750 million share buyback program and reaffirmed its revenue growth guidance of 14% for 2025, coinciding with its earnings report for the first quarter showing increased sales but decreased net income. In the past month, the company's share price saw a 4% rise, bolstered by broader market gains, as the S&P 500 extended a notable winning streak and investor sentiment was uplifted by strong employment data. Despite fluctuations due to Dexcom's mixed...
NYSE:KO
NYSE:KOBeverage

Coca-Cola (NYSE:KO) Declares US$0.51 Quarterly Dividend Payable July 1

Coca-Cola (NYSE:KO) recently affirmed its regular quarterly dividend of 51 cents per share, reinforcing its commitment to return value to shareholders. Over the last quarter, the company's share price grew by 12%, aligning with broader market trends driven by strong employment data and optimism in major indices. Coca-Cola's Q1 earnings displayed modest growth in net income and earnings per share, whereas sales saw a slight decline, possibly buoyed by solid corporate guidance and an ongoing...